Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion

Thomas C. Kreutzer, Claudia S. Alge, Armin Wolf, Daniel Kook, Johannes Bürger, Christian Kunze, Christos Haritoglou, Anselm Kampik, Siegfried Priglinger

British Journal of Ophthalmology · 2008 · 104 citations · 16 references

Abstract

Intravitreal injection of 1.25 mg bevacizumb appears to be an effective treatment option for branch retinal vein occlusion.

References

16